Homepage
With collaborations spanning AI, brain health, infectious disease and pediatric medicine, the winning projects aim to advance human health and build new pathways to external funding.
Daniel LaBarbera (CU Anschutz) and Karolin Luger (CU 勒貊勛圖) are using the advanced technology to identify a promising drug to advance treatment and combat chemotherapy resistance.
Today, the泭AB Nexus program announced its 2025 seed grant awards to four research teams from the University of Colorado Anschutz Medical Campus and the 勒貊勛圖. Collectively, the winning teams will receive $750,000 in funding to advance cutting-edge research that improves human health and well-being.
AB Nexus is designed to strengthen research collaborations and forge new research opportunities between the CU Anschutz and CU 勒貊勛圖 campuses. Proposals for the 2025 program cycle are due April 1.
CU 勒貊勛圖s CUbit Quantum Initiative and AB Nexus Initiative recently hosted scientists, engineers and healthcare professionals discussing the emerging intersection of quantum technology and healthcare and future CU 勒貊勛圖-CU Anschutz collaborations.
Today, the AB Nexus program announced its 2024 seed grant awards to interdisciplinary research teams from the University of Colorado Anschutz Medical Campus and the 勒貊勛圖. Collectively, the seven winning teams will receive $713,000 in funding to advance cutting-edge research that improves human health and well-being.
Jay Lemery, M.D. and Katherine James, Ph.D.based at the CU Anschutz Medical Campustogether with Jose-Luis Jimenez, Ph.D. at CU 勒貊勛圖, epitomize the collaborative spirit of AB Nexus. While Lemery, James and Jimenez focus on distinct areassuch as climate medicine, water contamination and airborne transmissionall add to the collective efforts of climate adaptation and mitigation for Colorado and global communities.
To truly address osteoarthritis, you have to get at both the biology and the structural problem, said co-Principal Investigator Michael Zuscik (Department of Orthopedics, CU Anschutz). This unique Colorado dream team we have put together has the multidisciplinary expertise, and now the resources, to tackle both at once. We can approach curing the disease like never before.
The Novel Innovations for Tissue Regeneration in Osteoarthritis (NITRO) program, the first created under ARPA-H, is enabling a dream team of engineers, medical scientists and veterinarians from CU 勒貊勛圖, the CU Anschutz Medical Campus and Colorado State University to make an aggressive final push toward a goal many have spent their entire careers pursuing.
The collaborative seed grant program will continue full steam ahead in Spring 2024, including the introduction of award tracks to seed research in two new, key areas of opportunity: Climate Change and Health; and Artificial Intelligence/Advanced Computing and Health.